The PE Ratio as of December 2025 (TTM) for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) is 1.18K

According to Shukra Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 1.18K. This represents a change of 948.71% compared to the average of 112.63 of the last 4 quarters.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Historical PE Ratio (quarterly & annually)

How has SHUKRAPHAR.BO PE Ratio performed in the past?

The mean historical PE Ratio of Shukra Pharmaceuticals Limited over the last ten years is 66.33K. The current 1.18K PE Ratio has changed 78.08% with respect to the historical average. Over the past ten years (40 quarters), SHUKRAPHAR.BO's PE Ratio was at its highest in in the March 2016 quarter at 454.27K. The PE Ratio was at its lowest in in the December 2015 quarter at -103812.34.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Shukra Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Average PE Ratio

How has SHUKRAPHAR.BO PE Ratio performed in the past?

The current PE Ratio of Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) PE Ratio vs. Peers

How is SHUKRAPHAR.BO’s PE Ratio compared to its peers?

Shukra Pharmaceuticals Limited’s PE Ratio is greater than Suraksha Diagnostic Limited (44.53), greater than Suraksha Diagnostic Limited (44.53), greater than TTK Healthcare Limited (22.26), greater than Megasoft Limited (9.35), greater than Bliss GVS Pharma Limited (16.66), greater than Bliss GVS Pharma Limited (16.66), greater than Tarsons Products Limited (43.86), greater than Tarsons Products Limited (43.86), greater than Syncom Formulations (India) Limited (21.14), greater than Syncom Formulations (India) Limited (21.14),

Build a custom stock screener for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shukra Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shukra Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.